InvestorsHub Logo
Followers 275
Posts 35867
Boards Moderated 2
Alias Born 04/05/2012

Re: None

Tuesday, 12/22/2015 10:03:29 AM

Tuesday, December 22, 2015 10:03:29 AM

Post# of 5235
**** Upon entering into the agreement, Aspire purchased $1 million of Biocept's common stock at $1.60 per share, representing an 8.1% premium over the closing price of $1.48 on December 21, 2015.

D1sclaimer: I am not a financial advisor or a stock promoter. I am an investor, Period! Do your own DD and make your own investment decisions.